Does COVID-19 Pandemic Reduce In-hospital Mortality?

• Sponsor: Kanuni Sultan Suleyman Training and Research Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT04480515
• Collaborator: (none)
• Enrollment: 5,000
• Location: 1
• Actual Duration (Months): 3.6
• Patients Per Site Per Month: 1371.1

Study Details

Study Description

Brief Summary

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Although it is suggested that hospital admissions are reduced due to some reasons such as trauma, during COVID-19 pandemic, it is controversial whether in-hospital mortality rates changed. Therefore this multi-centered study aimed to determine how in-hospital mortality effected during the pandemic period according to the specific patient groups.

Condition or Disease	Intervention/Treatment	Phase
Covid19; In-hospital Cardiac Arrest	Other: in-hospital mortality rate

Detailed Description

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Although it is suggested that hospital admissions are reduced due to some reasons such as trauma, during COVID-19 pandemic, it is controversial whether in-hospital mortality rates changed. Therefore this multi-centered study aimed to determine how in-hospital mortality effected during the pandemic period according to the specific patient groups. Thus, in case of a pandemic, it will be a guide in which patient groups healthcare providers should be more careful about.

Study Design

• Study Type: Observational
• Actual Enrollment: 5000 participants
• Observational Model: Cohort
• Time Perspective: Other
• Official Title: Does COVID-19 Pandemic Reduce In-hospital Mortality?
• Actual Study Start Date: Mar 11, 2020
• Actual Primary Completion Date: Jun 15, 2020
• Actual Study Completion Date: Jun 30, 2020

Outcome Measures

Primary Outcome Measures

1. In-hospital mortality [4 months]

   During the pandemic (March-July), deaths occurred in hospital will be evaluated.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Deaths, with all required data available, occurred within the study hospitals

• centers Accepted to participate with an informed consent

Exclusion Criteria:

• lack of consent

• lack of data

• deaths occurred outside the study hospitals

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Kanuni Sultan Suleyman Training and Research Hospital	Istanbul		Turkey	34303

Sponsors and Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Ramazan Guven, Professor, Kanuni Sultan Suleyman Training and Research Hospital
• ClinicalTrials.gov Identifier: NCT04480515
• Other Study ID Numbers: KSSEAH--IHM
• First Posted: Jul 21, 2020
• Last Update Posted: Jul 21, 2020
• Last Verified: Jul 1, 2020

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of Jul 21, 2020